+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Kidney Cancer Drugs Market Research Reports

US Renal Cell Carcinoma Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Renal Cell Carcinoma Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Renal Cell Carcinoma Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Renal Cell Carcinoma Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Diabetic Nephropathy Market and Competitive Landscape - 2021 - Product Thumbnail Image

Global Diabetic Nephropathy Market and Competitive Landscape - 2021

  • Report
  • August 2021
  • Global
From
Global Renal Cell Carcinoma Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Renal Cell Carcinoma Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
Kidney Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Kidney Cancer Treatment Drugs Markets in China

  • Report
  • September 2024
  • 244 Pages
  • China
From
Votrient - API Insight, 2022 - Product Thumbnail Image

Votrient - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Nexavar - API Insight, 2022 - Product Thumbnail Image

Nexavar - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Sutent - API Insight, 2022 - Product Thumbnail Image

Sutent - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Tarceva - API Insight, 2022 - Product Thumbnail Image

Tarceva - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Exeter Erlotinib hydrochloride tablet Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Exeter Erlotinib hydrochloride tablet Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2024
  • 93 Pages
  • Global
From
Renal Cell Carcinoma Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Renal Cell Carcinoma Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • August 2024
  • 93 Pages
  • Global
From
Everolimus Tablet Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Everolimus Tablet Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2024
  • 71 Pages
  • Global
From
Everolimus Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Everolimus Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • February 2024
  • 85 Pages
  • Global
From
Kidney Cancer Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Kidney Cancer Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 93 Pages
  • Global
From
Pazopanib API Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Pazopanib API Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 118 Pages
  • Global
From
Avastin Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Avastin Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • February 2024
  • 92 Pages
  • Global
From
Sorafenib Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Sorafenib Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 107 Pages
  • Global
From
Axitinib Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Axitinib Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 112 Pages
  • Global
From
Nephroblastoma Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Nephroblastoma Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 83 Pages
  • Global
From
Capecitabine Fumarate Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Capecitabine Fumarate Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 114 Pages
  • Global
From
Loading Indicator

The Kidney Cancer Drugs market is a subset of the pharmaceutical industry that focuses on the development and sale of drugs used to treat kidney cancer. These drugs are used to reduce the size of tumors, slow the growth of cancer cells, and reduce the spread of cancer to other parts of the body. Common treatments include chemotherapy, targeted therapy, immunotherapy, and surgery. The market is highly competitive, with many companies vying for market share. Major players include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and AstraZeneca. These companies are constantly researching and developing new drugs to improve the treatment of kidney cancer. Additionally, many smaller companies are also involved in the market, offering innovative treatments and therapies. Overall, the Kidney Cancer Drugs market is an important part of the pharmaceutical industry, providing treatments and therapies to improve the lives of those affected by kidney cancer. Show Less Read more